Related Experiment Videos
[Cytomegalic inclusion disease].
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris
|February 23, 1977
Summary
Cytomegalic inclusion disease, caused by a herpes group virus, presents with specific clinical signs in newborns. Diagnosis involves identifying cytomegalovirus viremia and antibody increases, especially in mononuclear syndromes negative for the Paul and Bunnell test.
Area of Science:
- Virology
- Infectious Diseases
- Pediatrics
Background:
- Cytomegalic inclusion disease (CID) is a congenital infection caused by a human herpesvirus, cytomegalovirus (CMV).
- First cultured in 1956, CID has been recognized in newborns in France since 1952.
- Clinical manifestations can vary, making early diagnosis challenging.
Purpose of the Study:
- To highlight key clinical indicators suggestive of cytomegalovirus infection in newborns.
- To emphasize the diagnostic value of specific laboratory findings in suspected cases of CID.
- To provide a concise overview of cytomegalic inclusion disease.
Main Methods:
- Review of clinical cases and diagnostic criteria for cytomegalic inclusion disease.
- Analysis of laboratory findings, including viral detection and antibody response.
- Correlation of clinical syndromes with laboratory evidence of cytomegalovirus infection.
Main Results:
- Mononuclear syndromes, particularly when negative for the Paul and Bunnell test, are significant indicators of potential CMV infection.
- The presence of cytomegalovirus (CMV) viremia supports the diagnosis.
- A rise in specific antibodies against CMV confirms recent or active infection.
Conclusions:
- Cytomegalic inclusion disease should be considered in the differential diagnosis of neonatal infections presenting with mononuclear syndromes.
- Diagnostic confirmation relies on detecting CMV viremia and a serological response.
- Early identification and diagnosis are crucial for managing cytomegalic inclusion disease in newborns.